Starpharma Holdings Ltd (SPL.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 4,912 | 8,289 | 2,939 | 4,682 | 1,798 |
| Cost of Goods | 1,224 | 632 | 1,120 | 2,776 | 791 |
| Gross Profit | 3,688 | 7,657 | 1,819 | 1,906 | 1,007 |
| Operating Expenses | 15,686 | 18,404 | 20,055 | 19,618 | 23,362 |
| Operating Income | -11,998 | -10,747 | -18,236 | -17,712 | -22,355 |
| Other Income | 2,008 | 2,582 | 2,598 | 1,558 | 2,623 |
| Pre-tax Income | -9,990 | -8,165 | -15,638 | -16,154 | -19,732 |
| Net Income Continuous | -9,990 | -8,165 | -15,638 | -16,154 | -19,732 |
| Net Income | $-9,990 | $-8,165 | $-15,638 | $-16,154 | $-19,732 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.04 | -0.04 | -0.05 |
| EBITDA(a) | $-10,928 | $-9,632 | $-17,042 | $-16,634 | $-21,421 |